HAUNA PAYNE: Open Payments
NPI 1972126456 · MONTROSE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$279 in 12 payments from 9 companies in 2025. Trend: 2023 $315 · 2024 $399 · 2025 $279
Food & beverage: $279
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $73 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Boston Scientific Corporation | 1 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Astellas Pharma US Inc | 1 | $23 |
| Amgen Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| PFIZER INC. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
Products named: REXULTI, QULIPTA, Axonics, VRAYLAR, Kerendia, Veozah, EVENITY, BEXSERO.
Industry payments across CO — which companies pay providers there.
